Article

Toric IOLs yield minimal residual refractive cylinder

In a 1-year follow-up study, 119 patients in whom a toric IOL (AcrySof Toric, Alcon Laboratories) had been implanted had excellent results, including minimal residual refractive cylinder. The lens, which is available in three toricities, provides very accurate results for several different patient populations.

Key Points

Dr. Ernest, associate clinical professor, Kresge Eye Institute, Wayne State University, Detroit, and a private practitioner in Jackson, MI, based his comments on a study of 119 patients who returned to the clinic 1 year after implantation of the toric IOL. Eighty-four patients had received a model SA60T3 lens, 14 had received a model SA60T4 lens, and 21 had received a model SA60T5 lens.

At the time of implantation, the following patients had been deemed suitable candidates for the toric IOL: patients with astigmatism undergoing cataract and refractive surgery, patients with astigmatism undergoing refractive lens exchange, patients with significant astigmatism undergoing monovision correction, patients with astigmatic and presbyopia or hyperopia considering LASIK, and patients with no refractive astigmatism but with corneal astigmatism that offsets the natural lens.

The patients who returned for this study underwent refraction using an autorefractor. Cylinder results from the refraction were averaged by lens toricity (T3, T4, or T5) to arrive at a mean residual refractive cylinder by lens model.

Mean residual refractive cylinder for patients who received the SA60T3 lens was 0.38 D. Patients who had received the SA60T4 lens had a mean residual refractive cylinder of 0.52 D; patients who had received the SA60T5 model had a mean of 0.57 D.

Dr. Ernest said that the manufacturer's toric calculator ( http://www.acrysoftoriccalculator.com/ ) is a valuable tool. "The calculator allows you to predict anticipated residual astigmatism based on incision location and induced astigmatism from the surgeon's incision."

The accurate results achieved in this study depend on proper lens model calculations and surgical techniques, he said.

"As far as putting the lens in position, it's important to mark the three- and nine-o'clock positions and remove all viscoelastic," Dr. Ernest said. "In addition, I use a two-handed technique to center the lens. You also want to make sure the lens is stable and that you have no shallowing of the anterior chamber."

Dr. Ernest concluded that he uses the toric IOL as a functional lens, not a premium lens.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.